Rhodium(III)-catalyzed indazole synthesis by C-H bond functionalization and cyclative capture

Journal of the American Chemical Society

Volumn 135, Issue 19, 2013, Pages 7122-7125

  Lian, Yajing ^a   Bergman, Robert G ^b   Lavis, Luke D ^c   Ellman, Jonathan A ^a  

^a YALE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARYL GROUP; C-H BOND; C-H BOND FUNCTIONALIZATION; INDAZOLE; N-SUBSTITUTION; REGIOSELECTIVE COUPLING; RHODIUM (III); SPECTROSCOPIC CHARACTERIZATION;

AZOBENZENE; FUNCTIONAL GROUPS;

CATALYSIS;

CARBON; HYDROGEN; INDAZOLE DERIVATIVE; RHODIUM; RHODIUM(III); UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; SYNTHESIS;

ALDEHYDES; AZO COMPOUNDS; CATALYSIS; FLUORESCENT DYES; INDAZOLES; RHODIUM; STEREOISOMERISM;

EID: 84877816334     PISSN: 00027863     EISSN: 15205126     Source Type: Journal    
DOI: 10.1021/ja402761p     Document Type: Article

References (57)

1. Lian, Y.; Bergman, R. B.; Ellman, J. A. Chem. Sci. 2012, 3, 3088
2. Lian, Y.; Huber, T.; Hesp, K. D.; Bergman, R. G.; Ellman, J. A. Angew. Chem., Int. Ed. 2013, 52, 629
3. Yang, L.; Correia, C. A.; Li, C.-J. Adv. Synth. Catal. 2011, 353, 1269
4. Li, Y.; Zhang, X.-S.; Chen, K.; He, K.-H.; Pan, F.; Li, B.-J.; Shi, Z.-J. Org. Lett. 2012, 14, 636
5. Park, J.; Park, E.; Kim, A.; Lee, Y.; Chi, K. W.; Kwak, J. H.; Jung, Y. H.; Kim, I. S. Org. Lett. 2011, 13, 4390
6. Sharma, S.; Park, E.; Park, J.; Kim, I. S. Org. Lett. 2012, 14, 906
7. Zhou, B.; Yang, Y.; Li, Y. Chem. Commun. 2012, 48, 5163
8. Shi, X.-Y.; Li, C.-J. Adv. Synth. Catal. 2012, 354, 2933
9. Tsai, A. S.; Tauchert, M. E.; Bergman, R. G.; Ellman, J. A. J. Am. Chem. Soc. 2011, 133, 1248
10. Li, Y.; Li, B.-J.; Wang, W.-H.; Huang, W.-P.; Zhang, X.-S.; Chen, K.; Shi, Z.-J. Angew. Chem., Int. Ed. 2011, 50, 2115
11. Tauchert, M. E.; Incarvito, C. D.; Rheingold, A. L.; Bergman, R. G.; Ellman, J. A. J. Am. Chem. Soc. 2012, 134, 1482
12. Hesp, K. D.; Bergman, R. G.; Ellman, J. A. Org. Lett. 2012, 14, 2304
13. Li, Y.; Zhang, X.-S.; Li, H.; Wang, W.-H.; Chen, K.; Li, B.-J.; Shi, Z.-J. Chem. Sci. 2012, 3, 1634
14. Li, Y.; Zhang, X.-S.; Zhu, Q.-L.; Shi, Z.-J. Org. Lett. 2012, 14, 4498
15. Zhou, B.; Yang, Y.-X.; Lin, S.; Li, Y.-C. Adv. Synth. Catal. 2013, 355, 360
16. Hesp, K. D.; Bergman, R. G.; Ellman, J. A. J. Am. Chem. Soc. 2011, 133, 11430
17. Zhou, B.; Hou, W.; Yang, Y.-X.; Li, Y.-C. Chem.-Eur. J. 2013, 19, 4701
18. Li, X.-W.; Yu, S.-J.; Wan, F.; Wan, B.-S.; Yu, X.-Z. Angew. Chem., Int. Ed. 2013, 52, 2577
19. Du, Y.; Hyster, T. K.; Rovis, T. Chem. Commun. 2011, 47, 12074
20. Zhu, C.; Xie, W.; Falck, J, R. Chem.-Eur. J. 2011, 17, 12591
21. Satoh, T.; Miura, M. Chem.-Eur. J. 2010, 16, 11212
22. Wencel-Delord, J.; Droge, T.; Liu, F.; Glorius, F. Chem. Soc. Rev. 2011, 40, 4740
23. Song, G.; Wang, F.; Li, X. Chem. Soc. Rev. 2012, 41, 3651
24. Neely, J. M.; Rovis, T. J. Am. Chem. Soc. 2013, 135, 66
25. Zhen, W.; Wang, F.; Zhao, M.; Du, Z.; Li, X. Angew. Chem., Int. Ed. 2013, 51, 11819
26. Hyster, T. K.; Knörr, L.; Ward, T. R.; Rovis, T. Science 2012, 338, 500
27. Ye, B.; Cramer, N. Science 2012, 338, 504
28. Neely, J. M.; Rovis, T. J. Am. Chem. Soc. 2013, 135, 66
29. Wang, H.; Grohmann, C.; Nimphius, C.; Glorius, F. J. Am. Chem. Soc. 2012, 134, 19595
30. Wang, H.; Glorius, F. Angew. Chem., Int. Ed. 2012, 51, 7318
31. Yamaguchi, J.; Yamaguchi, A. D.; Itami, K. Angew. Chem,. Int. Ed. 2012, 51, 8960
32. Colby, D. A.; Bergman, R. G.; Ellman, J. A. Chem. Rev. 2010, 110, 624
33. Lyons, T. W.; Sanford, M. S. Chem. Rev. 2010, 110, 1147
34. Chen, X.; Engle, K. M.; Wang, D.-H.; Yu, J.-Q. Angew. Chem., Int. Ed. 2009, 48, 5094
35. Seregin, I. V.; Gevorgyan, V. Chem. Soc. Rev. 2007, 36, 1173
36. Typing the names of the following drug and drug candidates into PubChem (http://pubchem.ncbi.nlm.nih.gov/) provides the compound structure, bioactivity, published studies, and information regarding ongoing clinical trials, applications, and usage: niraparib, granisetron, pazopanib, linifanib, axitinib, and GDC-0941.
37. Information on 2-substituted 2 H -indazole clinical candidates niraparib and pazopanib can be accessed according to the instructions provided in reference 11.
38. De Angelis, M.; Stossi, F.; Carlson, K. A.; Katzenellenbogen, B. S.; Katzenellenbogen, K. A. J. Med. Chem. 2005, 48, 1132
39. Haddadin, M. J.; Conrad, W. E.; Kurth, M. J. Mini-Rev. Med. Chem. 2012, 12, 1293
40. Sapeta, K.; Kerr, M. A. Sci. Synth., Knowledge Updates 2011, 1, 15
41. Hu, J.-T.; Cheng, Y.-F.; Yang, Y.-Q.; Rao, Y. Chem. Commun. 2011, 47, 10133
42. Kumar, M. R.; Park, A.; Park, N.; Lee, S. Org. Lett. 2011, 13, 3542
43. Halland, N.; Nazare, M.; R'kyek, O.; Alonso, J.; Urmann, M.; Lindenschmidt, A. Angew. Chem., Int. Ed. 2009, 48, 6879
44. Stokes, B. J.; Vogel, C. V.; Urnezis, L. K.; Pan, M.; Driver, T. G. Org. Lett. 2010, 12, 2884
45. Beharry, A. A.; Woolley, G. A. Chem. Soc. Rev. 2011, 40, 4422
46. Natansohn, A.; Rochon, P. Chem. Rev. 2002, 102, 4139
47. Ichimura, K. Chem. Rev. 2000, 100, 1847
48. Kleiman, J. P.; Dubeck, M. J. Am. Chem. Soc. 1963, 85, 1544
49. Murahashi, S.; Horiie, S. J. Am. Chem. Soc. 1956, 78, 4816
50. Kakiuchi, F.; Matsumoto, M.; Tsuchiya, K.; Igi, K.; Hayamizu, T.; Chatani, N.; Murai, S. J. Organomet. Chem. 2003, 686, 134
51. Dick, A. R.; Hull, K. L.; Sanford, M. S. J. Am. Chem. Soc. 2004, 126, 2300
52. Ma, X.-T.; Tian, S.-K. Adv. Synth. Catal. 2013, 355, 337
53. Li, H.-J.; Li, P.-H.; Wang, L. Org. Lett. 2013, 15, 620
54. Lavis, L. D.; Raines, R. T. ACS Chem. Biol. 2008, 3, 142-155
55. Kiyose, K.; Kojima, H.; Nagano, T. Chem. Asian J. 2008, 3, 506-515
56. Grimm, J. B.; Heckman, L. M.; Lavis, L. D. Prog. Mol. Biol. Transl. Sci. 2013, 113, 1-34
57. Harris, J. L.; Backes, B. J.; Leonetti, F.; Mahrus, S.; Ellman, J. A.; Craik, C. S. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 7754